{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,7,9]],"date-time":"2026-07-09T10:23:17Z","timestamp":1783592597838,"version":"3.55.0"},"reference-count":52,"publisher":"MDPI AG","issue":"13","license":[{"start":{"date-parts":[[2022,6,21]],"date-time":"2022-06-21T00:00:00Z","timestamp":1655769600000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"funder":[{"name":"the National Health and Medical Research Council (NHMRC)"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["IJMS"],"abstract":"<jats:p>Positron emission tomography is the imaging modality of choice when it comes to the high sensitivity detection of key markers of thrombosis and inflammation, such as activated platelets. We, previously, generated a fluorine-18 labelled single-chain antibody (scFv) against ligand-induced binding sites (LIBS) on activated platelets, binding it to the highly abundant platelet glycoprotein integrin receptor IIb\/IIIa. We used a non-site-specific bio conjugation approach with N-succinimidyl-4-[18F]fluorobenzoate (S[18F]FB), leading to a mixture of products with reduced antigen binding. In the present study, we have developed and characterised a novel fluorine-18 PET radiotracer, based on this antibody, using site-specific bio conjugation to engineer cysteine residues with N-[2-(4-[18F]fluorobenzamido)ethyl]maleimide ([18F]FBEM). ScFvanti-LIBS and control antibody mut-scFv, with engineered C-terminal cysteine, were reduced, and then, they reacted with N-[2-(4-[18F]fluorobenzamido)ethyl]maleimide ([18F]FBEM). Radiolabelled scFv was injected into mice with FeCl3-induced thrombus in the left carotid artery. Clots were imaged in a PET MR imaging system, and the amount of radioactivity in major organs was measured using an ionisation chamber and image analysis. Assessment of vessel injury, as well as the biodistribution of the radiolabelled scFv, was studied. In the in vivo experiments, we found uptake of the targeted tracer in the injured vessel, compared with the non-injured vessel, as well as a high uptake of both tracers in the kidney, lung, and muscle. As expected, both tracers cleared rapidly via the kidney. Surprisingly, a large quantity of both tracers was taken up by organs with a high glutathione content, such as the muscle and lung, due to the instability of the maleimide cysteine bond in vivo, which warrants further investigations. This limits the ability of the novel antibody radiotracer 18F-scFvanti-LIBS to bind to the target in vivo and, therefore, as a useful agent for the sensitive detection of activated platelets. We describe the first fluorine-18 variant of the scFvanti-LIBS against activated platelets using site-specific bio conjugation.<\/jats:p>","DOI":"10.3390\/ijms23136886","type":"journal-article","created":{"date-parts":[[2022,6,21]],"date-time":"2022-06-21T21:55:19Z","timestamp":1655848519000},"page":"6886","update-policy":"https:\/\/doi.org\/10.3390\/mdpi_crossmark_policy","source":"Crossref","is-referenced-by-count":5,"title":["18F Site-Specific Labelling of a Single-Chain Antibody against Activated Platelets for the Detection of Acute Thrombosis in Positron Emission Tomography"],"prefix":"10.3390","volume":"23","author":[{"given":"Katie S.","family":"Ardipradja","sequence":"first","affiliation":[{"name":"Department of Molecular Imaging and Therapy, Austin Health, University of Melbourne, Heidelberg 3084, Australia"},{"name":"Atherothrombosis and Vascular Biology Laboratory, Baker Heart and Diabetes Institute, Melbourne 3004, Australia"},{"name":"CSIRO\u2014Geelong, Australian Animal Health Laboratory (AAHL), Australian Centre for Disease Preparedness, East Geelong 3219, Australia"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Christian W.","family":"Wichmann","sequence":"additional","affiliation":[{"name":"Department of Molecular Imaging and Therapy, Austin Health, University of Melbourne, Heidelberg 3084, Australia"},{"name":"Olivia Newton-John Cancer Research Institute, La Trobe University, Melbourne 3086, Australia"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Kevin","family":"Hickson","sequence":"additional","affiliation":[{"name":"Department of Molecular Imaging and Therapy, Austin Health, University of Melbourne, Heidelberg 3084, Australia"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Angela","family":"Rigopoulos","sequence":"additional","affiliation":[{"name":"Olivia Newton-John Cancer Research Institute, La Trobe University, Melbourne 3086, Australia"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Karen M.","family":"Alt","sequence":"additional","affiliation":[{"name":"Vascular Biotechnology Laboratory, Baker Heart and Diabetes Institute, Melbourne 3004, Australia"},{"name":"Australian Centre for Blood Diseases, Central Clinical School, Monash University, Melbourne 3004, Australia"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Hannah A.","family":"Pearce","sequence":"additional","affiliation":[{"name":"Vascular Biotechnology Laboratory, Baker Heart and Diabetes Institute, Melbourne 3004, Australia"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-8658-7399","authenticated-orcid":false,"given":"Xiaowei","family":"Wang","sequence":"additional","affiliation":[{"name":"Atherothrombosis and Vascular Biology Laboratory, Baker Heart and Diabetes Institute, Melbourne 3004, Australia"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Graeme","family":"O\u2019Keefe","sequence":"additional","affiliation":[{"name":"Department of Molecular Imaging and Therapy, Austin Health, University of Melbourne, Heidelberg 3084, Australia"},{"name":"Olivia Newton-John Cancer Research Institute, La Trobe University, Melbourne 3086, Australia"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Andrew M.","family":"Scott","sequence":"additional","affiliation":[{"name":"Department of Molecular Imaging and Therapy, Austin Health, University of Melbourne, Heidelberg 3084, Australia"},{"name":"Olivia Newton-John Cancer Research Institute, La Trobe University, Melbourne 3086, Australia"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Karlheinz","family":"Peter","sequence":"additional","affiliation":[{"name":"Atherothrombosis and Vascular Biology Laboratory, Baker Heart and Diabetes Institute, Melbourne 3004, Australia"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-7114-4023","authenticated-orcid":false,"given":"Christoph E.","family":"Hagemeyer","sequence":"additional","affiliation":[{"name":"Vascular Biotechnology Laboratory, Baker Heart and Diabetes Institute, Melbourne 3004, Australia"},{"name":"Australian Centre for Blood Diseases, Central Clinical School, Monash University, Melbourne 3004, Australia"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Uwe","family":"Ackermann","sequence":"additional","affiliation":[{"name":"Department of Molecular Imaging and Therapy, Austin Health, University of Melbourne, Heidelberg 3084, Australia"},{"name":"Olivia Newton-John Cancer Research Institute, La Trobe University, Melbourne 3086, Australia"}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"1968","published-online":{"date-parts":[[2022,6,21]]},"reference":[{"key":"ref_1","doi-asserted-by":"crossref","first-page":"2708","DOI":"10.1161\/01.CIR.0000020548.60110.76","article-title":"Imaging atherosclerotic plaque inflammation with [18F]-fluorodeoxyglucose positron emission tomography","volume":"105","author":"Rudd","year":"2002","journal-title":"Circulation"},{"key":"ref_2","doi-asserted-by":"crossref","first-page":"38","DOI":"10.1038\/nrcardio.2009.201","article-title":"PET and SPECT in cardiovascular molecular imaging","volume":"7","author":"Dobrucki","year":"2010","journal-title":"Nat. Rev. Cardiol."},{"key":"ref_3","doi-asserted-by":"crossref","first-page":"220","DOI":"10.1016\/j.acra.2015.09.008","article-title":"PET\/MRI: Emerging clinical applications in oncology","volume":"23","author":"Fraum","year":"2016","journal-title":"Acad. Radiol."},{"key":"ref_4","doi-asserted-by":"crossref","first-page":"1004","DOI":"10.1007\/s00259-013-2686-2","article-title":"Current role of FDG PET\/CT in lymphoma","volume":"41","author":"Kostakoglu","year":"2014","journal-title":"Eur. J. Nucl. Med. Mol. Imaging"},{"key":"ref_5","doi-asserted-by":"crossref","first-page":"214","DOI":"10.1148\/radiol.2015142920","article-title":"Stage III non-small cell lung cancer: Prognostic value of FDG PET quantitative imaging features combined with clinical prognostic factors","volume":"278","author":"Fried","year":"2016","journal-title":"Radiology"},{"key":"ref_6","doi-asserted-by":"crossref","first-page":"140","DOI":"10.1016\/j.drudis.2016.09.020","article-title":"Molecular imaging in oncology drug development","volume":"22","author":"Mudd","year":"2017","journal-title":"Drug Discov. Today"},{"key":"ref_7","doi-asserted-by":"crossref","first-page":"A64","DOI":"10.1016\/j.ejrad.2017.01.018","article-title":"PET\/MRI in children","volume":"94","author":"Gatidis","year":"2017","journal-title":"Eur. J. Radiol."},{"key":"ref_8","first-page":"29","article-title":"Low-dose PET\/CT and full-dose contrast-enhanced CT at the initial staging of localized diffuse large B-cell lymphomas","volume":"9","author":"Mercadal","year":"2016","journal-title":"Clin. Med. Insights Blood Disord."},{"key":"ref_9","doi-asserted-by":"crossref","unstructured":"Wan, S., and Bomanji, J. (2018). PET\/MRI in Neuroendocrine Tumours. PET\/MRI in Oncology, Springer.","DOI":"10.1007\/978-3-319-68517-5_16"},{"key":"ref_10","doi-asserted-by":"crossref","first-page":"593","DOI":"10.1161\/CIRCRESAHA.110.232678","article-title":"Molecular imaging of coronary atherosclerosis and myocardial infarction: Considerations for the bench and perspectives for the clinic","volume":"108","author":"Leuschner","year":"2011","journal-title":"Circ. Res."},{"key":"ref_11","doi-asserted-by":"crossref","first-page":"330","DOI":"10.1161\/CIRCRESAHA.116.307971","article-title":"Noninvasive molecular imaging of disease activity in atherosclerosis","volume":"119","author":"Dweck","year":"2016","journal-title":"Circ. Res."},{"key":"ref_12","unstructured":"WHO (2013). Global Action Plan for the Prevention and Control of Noncommunicable Diseases 2013\u20132020, World Health Organization. Available online: https:\/\/apps.who.int\/iris\/handle\/10665\/94384."},{"key":"ref_13","doi-asserted-by":"crossref","first-page":"1340","DOI":"10.1161\/CIRCRESAHA.115.306841","article-title":"Global burden of thrombosis: Table","volume":"118","author":"Wendelboe","year":"2016","journal-title":"Circ. Res."},{"key":"ref_14","doi-asserted-by":"crossref","first-page":"368","DOI":"10.1038\/nrneph.2017.51","article-title":"The immunology of atherosclerosis","volume":"13","author":"Hansson","year":"2017","journal-title":"Nat. Rev. Nephrol."},{"key":"ref_15","doi-asserted-by":"crossref","first-page":"52","DOI":"10.2174\/157016108783331295","article-title":"Endothelial dysfunction, impaired endogenous platelet inhibition and platelet activation in diabetes and atherosclerosis","volume":"6","author":"Bauersachs","year":"2008","journal-title":"Curr. Vasc. Pharmacol."},{"key":"ref_16","doi-asserted-by":"crossref","first-page":"1685","DOI":"10.1056\/NEJMra043430","article-title":"Inflammation, atherosclerosis, and coronary artery disease","volume":"352","author":"Hansson","year":"2005","journal-title":"N. Engl. J. Med."},{"key":"ref_17","doi-asserted-by":"crossref","first-page":"1852","DOI":"10.1161\/CIRCRESAHA.114.302721","article-title":"Mechanisms of plaque formation and rupture","volume":"114","author":"Bentzon","year":"2014","journal-title":"Circ. Res."},{"key":"ref_18","doi-asserted-by":"crossref","first-page":"1506","DOI":"10.1161\/CIRCRESAHA.113.300512","article-title":"Platelets as cellular effectors of inflammation in vascular diseases","volume":"112","author":"Rondina","year":"2013","journal-title":"Circ. Res."},{"key":"ref_19","doi-asserted-by":"crossref","first-page":"1282","DOI":"10.1161\/ATVBAHA.108.179739","article-title":"Concept of vulnerable\/unstable plaque","volume":"30","author":"Finn","year":"2010","journal-title":"Arterioscler. Thromb. Vasc. Biol."},{"key":"ref_20","doi-asserted-by":"crossref","first-page":"3117","DOI":"10.1161\/CIRCULATIONAHA.111.030312","article-title":"Novel single chain antibody targeted microbubbles for molecular ultrasound imaging pf thrombosis: Validation of a unique noninvasive method for rapid and sensitive detection of thrombi and monitoring of success or failure in mice","volume":"125","author":"Wang","year":"2012","journal-title":"Circulation"},{"key":"ref_21","doi-asserted-by":"crossref","first-page":"6115","DOI":"10.1002\/anie.201402613","article-title":"Enzyme-mediated site-specific bioconjugation of metal complexes to proteins: Sortase-mediated coupling of copper-64 to a single-chain antibody","volume":"53","author":"Paterson","year":"2014","journal-title":"Angew. Chem. Int. Ed."},{"key":"ref_22","doi-asserted-by":"crossref","first-page":"229","DOI":"10.1016\/j.nucmedbio.2013.12.006","article-title":"Detection of activated platelets in a mouse model of carotid artery thrombosis with 18F-labeled single-chain antibodies","volume":"41","author":"Ardipradja","year":"2014","journal-title":"Nucl. Med. Biol."},{"key":"ref_23","doi-asserted-by":"crossref","first-page":"1862","DOI":"10.2967\/jnumed.107.043216","article-title":"Dual-function probe for PET and near-infrared fluorescence imaging of tumor vasculature","volume":"48","author":"Cai","year":"2007","journal-title":"J. Nucl. Med."},{"key":"ref_24","doi-asserted-by":"crossref","first-page":"17","DOI":"10.4161\/mabs.4.1.18347","article-title":"Disulfide bond structures of IgG molecules","volume":"4","author":"Liu","year":"2012","journal-title":"mAbs"},{"key":"ref_25","doi-asserted-by":"crossref","first-page":"1","DOI":"10.3390\/ijms12010001","article-title":"Stabilization of the single-chain fragment variable by an interdomain disulfide bond and its effect on antibody affinity","volume":"12","author":"Zhao","year":"2010","journal-title":"Int. J. Mol. Sci."},{"key":"ref_26","doi-asserted-by":"crossref","first-page":"263","DOI":"10.1007\/BF01025358","article-title":"Cross-linking of protein by \u03c9-maleimido alkanoylN-hydroxysuccinimido esters","volume":"2","author":"Partis","year":"1983","journal-title":"J. Protein Chem."},{"key":"ref_27","doi-asserted-by":"crossref","first-page":"362","DOI":"10.1006\/prep.2000.1258","article-title":"A modified metal-ion affinity chromatography procedure for the purification of histidine-tagged recombinant proteins expressed in Drosophila S2 cells","volume":"19","author":"Lehr","year":"2000","journal-title":"Protein Expr. Purif."},{"key":"ref_28","doi-asserted-by":"crossref","first-page":"115","DOI":"10.1002\/jlcr.3175","article-title":"Fully automated synthesis and coupling of [18F]FBEM to glutathione using the iPHASE FlexLab module","volume":"57","author":"Ackermann","year":"2014","journal-title":"J. Label. Compd. Radiopharm."},{"key":"ref_29","doi-asserted-by":"crossref","first-page":"697","DOI":"10.1016\/j.jasms.2004.01.005","article-title":"Fragmentation of protonated ions of peptides containing cysteine, cysteine sulfinic acid, and cysteine sulfonic acid","volume":"15","author":"Wang","year":"2004","journal-title":"J. Am. Soc. Mass Spectrom."},{"key":"ref_30","doi-asserted-by":"crossref","first-page":"258","DOI":"10.1161\/CIRCULATIONAHA.107.753657","article-title":"Magnetic resonance imaging contrast agent targeted toward activated platelets allows in vivo detection of thrombosis and monitoring of thrombolysis","volume":"118","author":"Muhlen","year":"2008","journal-title":"Circulation"},{"key":"ref_31","doi-asserted-by":"crossref","first-page":"31","DOI":"10.1016\/j.biomaterials.2017.04.037","article-title":"Molecular imaging of activated platelets via antibody-targeted ultra-small iron oxide nanoparticles displaying unique dual MRI contrast","volume":"134","author":"Ta","year":"2017","journal-title":"Biomaterials"},{"key":"ref_32","doi-asserted-by":"crossref","first-page":"2855","DOI":"10.1021\/mp500209a","article-title":"Single-Chain antibody conjugated to a cage amine chelator and labeled with positron-emitting copper-64 for diagnostic imaging of activated platelets","volume":"11","author":"Alt","year":"2014","journal-title":"Mol. Pharm."},{"key":"ref_33","doi-asserted-by":"crossref","first-page":"1282","DOI":"10.1021\/bc050201y","article-title":"Reduction\u2212alkylation strategies for the modification of specific monoclonal antibody disulfides","volume":"16","author":"Sun","year":"2005","journal-title":"Bioconjug. Chem."},{"key":"ref_34","doi-asserted-by":"crossref","first-page":"478","DOI":"10.1016\/j.jmb.2008.01.022","article-title":"Disulfide bond introduction for general stabilization of immunoglobulin heavy-chain variable domains","volume":"377","author":"Saerens","year":"2008","journal-title":"J. Mol. Biol."},{"key":"ref_35","doi-asserted-by":"crossref","first-page":"1970","DOI":"10.1074\/jbc.M111.242818","article-title":"Dual beneficial effect of interloop disulfide bond for single domain antibody fragments","volume":"287","author":"Govaert","year":"2012","journal-title":"J. Biol. Chem."},{"key":"ref_36","doi-asserted-by":"crossref","first-page":"101","DOI":"10.1016\/S0022-1759(00)00243-X","article-title":"Effects of unpaired cysteines on yield, solubility and activity of different recombinant antibody constructs expressed in E. coli","volume":"242","author":"Schmiedl","year":"2000","journal-title":"J. Immunol. Methods"},{"key":"ref_37","doi-asserted-by":"crossref","first-page":"4769","DOI":"10.1158\/1078-0432.CCR-10-0987","article-title":"Engineered thio-trastuzumab-DM1 conjugate with an improved therapeutic index to target human epidermal growth factor receptor 2-positive breast cancer","volume":"16","author":"Junutula","year":"2010","journal-title":"Clin. Cancer Res."},{"key":"ref_38","doi-asserted-by":"crossref","first-page":"30445","DOI":"10.1074\/jbc.M001672200","article-title":"Site-specific conjugation on serine \u2192 cysteine variant monoclonal antibodies","volume":"275","author":"Stimmel","year":"2000","journal-title":"J. Biol. Chem."},{"key":"ref_39","doi-asserted-by":"crossref","first-page":"197","DOI":"10.1006\/prep.2000.1239","article-title":"Endogenous glutathione-binding proteins of insect cell lines: Characterization and removal from glutathione S-transferase (GST) fusion proteins","volume":"19","author":"Bichet","year":"2000","journal-title":"Protein Expr. Purif."},{"key":"ref_40","doi-asserted-by":"crossref","first-page":"9673","DOI":"10.1158\/0008-5472.CAN-06-1480","article-title":"In vitro and in vivo characterization of 64Cu-labeled Abegrin, a humanized monoclonal antibody against integrin \u03b1v\u03b23","volume":"66","author":"Cai","year":"2006","journal-title":"Cancer Res."},{"key":"ref_41","doi-asserted-by":"crossref","first-page":"576","DOI":"10.1161\/01.CIR.103.4.576","article-title":"Plasminogen activator inhibitor-1 and its cofactor vitronectin stabilize arterial thrombi after vascular injury in mice","volume":"103","author":"Konstantinides","year":"2001","journal-title":"Circulation"},{"key":"ref_42","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1016\/S0002-9440(10)63270-1","article-title":"Mouse models of arteriosclerosis: From arterial injuries to vascular grafts","volume":"165","author":"Xu","year":"2004","journal-title":"Am. J. Pathol."},{"key":"ref_43","doi-asserted-by":"crossref","first-page":"184","DOI":"10.1038\/nbt.2108","article-title":"Conjugation site modulates the in vivo stability and therapeutic activity of antibody-drug conjugates","volume":"30","author":"Shen","year":"2012","journal-title":"Nat. Biotechnol."},{"key":"ref_44","doi-asserted-by":"crossref","first-page":"534","DOI":"10.1034\/j.1399-3003.2000.016003534.x","article-title":"Oxidative stress and regulation of glutathione in lung inflammation","volume":"16","author":"Rahman","year":"2000","journal-title":"Eur. Respir. J."},{"key":"ref_45","doi-asserted-by":"crossref","first-page":"962","DOI":"10.1172\/JCI114798","article-title":"Antioxidant macromolecules in the epithelial lining fluid of the normal human lower respiratory tract","volume":"86","author":"Cantin","year":"1990","journal-title":"J. Clin. Investig."},{"key":"ref_46","doi-asserted-by":"crossref","first-page":"1946","DOI":"10.1021\/bc200148v","article-title":"Tunable degradation of maleimide\u2013thiol adducts in reducing environments","volume":"22","author":"Baldwin","year":"2011","journal-title":"Bioconjug. Chem."},{"key":"ref_47","doi-asserted-by":"crossref","first-page":"759","DOI":"10.1021\/bc7004329","article-title":"Contribution of linker stability to the activities of anticancer immunoconjugates","volume":"19","author":"Alley","year":"2008","journal-title":"Bioconjug. Chem."},{"key":"ref_48","doi-asserted-by":"crossref","first-page":"145","DOI":"10.1021\/bc5005262","article-title":"Long-term stabilization of maleimide\u2013thiol conjugates","volume":"26","author":"Fontaine","year":"2015","journal-title":"Bioconjug. Chem."},{"key":"ref_49","doi-asserted-by":"crossref","first-page":"671","DOI":"10.1002\/jlcr.1892","article-title":"A simplified protocol for the automated production of succinimidyl 4-[18F]fluorobenzoate on an IBA synthera module","volume":"54","author":"Ackermann","year":"2011","journal-title":"J. Label. Compd. Radiopharm."},{"key":"ref_50","doi-asserted-by":"crossref","first-page":"4362","DOI":"10.1093\/nar\/24.21.4362","article-title":"An efficient DDAB-mediated transfection of Drosophila S2 cells","volume":"24","author":"Han","year":"1996","journal-title":"Nucleic Acids Res."},{"key":"ref_51","doi-asserted-by":"crossref","first-page":"137","DOI":"10.1016\/j.biomaterials.2015.02.088","article-title":"Immuno-magnetoliposomes targeting activated platelets as a potentially human-compatible MRI contrast agent for targeting atherothrombosis","volume":"53","author":"Meier","year":"2015","journal-title":"Biomaterials"},{"key":"ref_52","doi-asserted-by":"crossref","first-page":"1083","DOI":"10.1161\/CIRCRESAHA.114.302514","article-title":"Towards effective and safe thrombolysis and thromboprophylaxis: Preclinical testing of a novel antibody-targeted recombinant plasminogen activator directed against activated platelets","volume":"114","author":"Wang","year":"2014","journal-title":"Circ. Res."}],"container-title":["International Journal of Molecular Sciences"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.mdpi.com\/1422-0067\/23\/13\/6886\/pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,10,10]],"date-time":"2025-10-10T23:36:22Z","timestamp":1760139382000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.mdpi.com\/1422-0067\/23\/13\/6886"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2022,6,21]]},"references-count":52,"journal-issue":{"issue":"13","published-online":{"date-parts":[[2022,7]]}},"alternative-id":["ijms23136886"],"URL":"https:\/\/doi.org\/10.3390\/ijms23136886","relation":{},"ISSN":["1422-0067"],"issn-type":[{"value":"1422-0067","type":"electronic"}],"subject":[],"published":{"date-parts":[[2022,6,21]]}}}